Variant report
Variant | rs35919434 |
---|---|
Chromosome Location | chr2:46636143-46636144 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:46613200-46644200 | Weak transcription | Aorta | Aorta |
2 | chr2:46630600-46638600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr2:46631200-46639600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr2:46632600-46636200 | Weak transcription | K562 | blood |
5 | chr2:46633400-46636400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
6 | chr2:46633600-46639000 | Enhancers | Esophagus | oesophagus |
7 | chr2:46633800-46637800 | Enhancers | Pancreas | Pancrea |
8 | chr2:46633800-46638800 | Enhancers | Stomach Mucosa | stomach |
9 | chr2:46633800-46642000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr2:46634400-46636200 | Enhancers | Lung | lung |
11 | chr2:46634400-46637200 | Enhancers | Colonic Mucosa | Colon |
12 | chr2:46634600-46639400 | Enhancers | HMEC | breast |
13 | chr2:46634800-46637000 | Enhancers | Placenta | Placenta |
14 | chr2:46634800-46637800 | Weak transcription | Gastric | stomach |
15 | chr2:46634800-46641800 | Weak transcription | Spleen | Spleen |
16 | chr2:46635200-46637000 | Enhancers | Duodenum Mucosa | Duodenum |
17 | chr2:46635200-46637400 | Enhancers | Stomach Smooth Muscle | stomach |
18 | chr2:46635400-46637200 | Enhancers | Fetal Intestine Large | intestine |
19 | chr2:46635400-46637200 | Enhancers | Fetal Intestine Small | intestine |
20 | chr2:46635400-46637200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
21 | chr2:46635400-46637200 | Flanking Active TSS | Hela-S3 | cervix |
22 | chr2:46635400-46639400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
23 | chr2:46635600-46636800 | Enhancers | NHLF | lung |
24 | chr2:46635600-46637200 | Flanking Active TSS | HepG2 | liver |
25 | chr2:46635600-46637600 | Enhancers | Liver | Liver |
26 | chr2:46635800-46636400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
27 | chr2:46635800-46636400 | Enhancers | Left Ventricle | heart |
28 | chr2:46635800-46636400 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
29 | chr2:46635800-46636600 | Enhancers | NH-A | brain |
30 | chr2:46635800-46636800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
31 | chr2:46635800-46636800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
32 | chr2:46635800-46636800 | Flanking Active TSS | A549 | lung |
33 | chr2:46635800-46636800 | Enhancers | Osteobl | bone |
34 | chr2:46635800-46637000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
35 | chr2:46635800-46637000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
36 | chr2:46635800-46637200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
37 | chr2:46635800-46637200 | Enhancers | Right Atrium | heart |
38 | chr2:46635800-46637600 | Enhancers | Adipose Nuclei | Adipose |
39 | chr2:46635800-46637800 | Enhancers | NHEK | skin |
40 | chr2:46636000-46636200 | Enhancers | Muscle Satellite Cultured Cells | -- |
41 | chr2:46636000-46636200 | Flanking Bivalent TSS/Enh | Foreskin Fibroblast Primary Cells skin02 | Skin |
42 | chr2:46636000-46636200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
43 | chr2:46636000-46636400 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
44 | chr2:46636000-46636400 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
45 | chr2:46636000-46636800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
46 | chr2:46636000-46637000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
47 | chr2:46636000-46637800 | Enhancers | Right Ventricle | heart |
48 | chr2:46636000-46639400 | Enhancers | Skeletal Muscle Female | skeletal muscle |